Efficacy of Tirzepatide Dual <scp>GIP</scp> / <scp>GLP</scp> ‐1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real‐World Propensity Score‐Matched Study

Our results demonstrate that tirzepatide, when used as an adjunctive therapy, provides significant therapeutic benefits in IIH management, particularly in improving papilledema and visual outcomes. Our findings suggest that dual GIP/GLP-1 receptor activation may offer advantages over traditional single-receptor therapies, potentially through enhanced metabolic regulation and direct effects on ICP dynamics.

Authors

Institutions

Publication Details

Journal
Endocrinology Diabetes & Metabolism
Published
2025-02-13
DOI
https://doi.org/10.1002/edm2.70019
Citations
12
Primary Topic
Cerebral Venous Sinus Thrombosis
Type
article
Field-Weighted Citation Impact
16.67

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy of Tirzepatide Dual GIP / GLP ‐1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real‐World Propensity Score‐Matched Study

Neil Haranhalli, Deepak Khatri, David Altschul, Ahmed Saad Al Zomia et al.
12 citations
Endocrinology Diabetes & Metabolism
Cerebral Venous Sinus Thrombosis
16.67
article

Efficacy of Tirzepatide Dual GIP / GLP ‐1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real‐World Propensity Score‐Matched Study

Neil Haranhalli, Deepak Khatri, David Altschul, Ahmed Saad Al Zomia, Muhammed Amir Essibayi, Adam Andrew Dmytriw, Hammam A Alotaibi, Oday Atallah, Hana J Abukhadijah, Mohammed A. Azab, Amanda Baker, Nathan Farkas, Adam Elswedy, Ahmed Y. Azzam, Ahmed Alamoud, Mahmoud M Morsy, Osman Elamin
article en
12 citations

Abstract

Our results demonstrate that tirzepatide, when used as an adjunctive therapy, provides significant therapeutic benefits in IIH management, particularly in improving papilledema and visual outcomes. Our findings suggest that dual GIP/GLP-1 receptor activation may offer advantages over traditional single-receptor therapies, potentially through enhanced metabolic regulation and direct effects on ICP dynamics.

Endocrinology Diabetes & MetabolismVol. 8(2)
Uppsala University (SE), Brigham and Women's Hospital (US), St. Michael's Hospital (CA), Albert Einstein College of Medicine (US), Cleveland Clinic (US), Montefiore Medical Center (US), Riyadh Armed Forces Hospital (SA), Harvard University (US), University of Toronto (CA), Jordan Hospital (JO), Medizinische Hochschule Hannover (DE), Massachusetts General Hospital (US), Neurological Surgery (US), October 6 University (EG), Hamad Medical Corporation (QA), King Khalid University (SA)
Qatar National Library, National Center for Advancing Translational Sciences
Good health and well-being
Openalex Percentile: Top 1%
Cerebral Venous Sinus Thrombosis
16.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.